This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Robert Mühlbacher: Innovator in Antibody Development
Introduction
Robert Mühlbacher is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions for medical challenges, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Mühlbacher holds a patent for an antibody targeting osteoclast-related protein Siglec-15. This isolated antibody is capable of binding Siglec-15, which inhibits osteoclast formation and/or osteoclastic bone resorption. The heavy chain of the antibody comprises a CDRH1 with at least 80% sequence identity to SEQ ID NO: 106, a CDRH2 with at least 80% sequence identity to SEQ ID NO: 107, and a CDRH3 with at least 80% sequence identity to one of SEQ ID NOS: 35, 45, 55, 65, or 80. The light chain of the antibody includes a CDRL1 with at least 80% sequence identity to SEQ ID NO: 73 or 83, a CDRL2 with at least 80% sequence identity to SEQ ID NO: 108, and a CDRL3 with at least 80% sequence identity to one of SEQ ID NOS: 40, 50, 60, 70, 90, 100, or 109. This patent represents a significant advancement in the treatment of bone-related diseases.
Career Highlights
Mühlbacher is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the field of antibody research. His work has been instrumental in developing therapies that target specific proteins involved in bone resorption, contributing to improved treatment options for patients.
Collaborations
He collaborates with esteemed colleagues such as Ichiro Watanabe and Yoshiharu Hiruma, enhancing the research and development efforts within his team. Their combined expertise fosters a productive environment for innovation.
Conclusion
Robert Mühlbacher is a prominent figure in the field of biotechnology, particularly known for his innovative work on antibodies. His contributions are paving the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile